Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01359267 · ClinicalTrials.gov registry record · Early Phase 1
Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer
A Early Phase 1 study, sponsored by University of Chicago.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 12
- Enrollment target
NCT01359267 is a Early Phase 1 study that has completed, run by University of Chicago. The registered enrollment target is 12 participants.
The verdict
NCT01359267, a Early Phase 1 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain preliminary information on the potential of 99m Tc-EC-DG SPECT imaging to distinguish cancer from non cancer.
Interventions
- DRUG 99mTc-EC-DG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-04-19 |
| Est. Completion | 2015-09-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01359267
The ClinicalTrials.gov registry entry for NCT01359267 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 99mTc-EC-DG is the first listed.
NCT01359267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01359267 about?
NCT01359267 is a clinical study titled "Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer". The purpose of this study is to obtain preliminary information on the potential of 99m Tc-EC-DG SPECT imaging to distinguish cancer from non cancer.
What is the current status of trial NCT01359267?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 12 participants. The study started on 2011-04-19. Estimated completion is 2015-09-15.
What interventions are being tested in trial NCT01359267?
The interventions under investigation include: 99mTc-EC-DG (DRUG).
Who is sponsoring clinical trial NCT01359267?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.